Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Taiwanese (TAIEX) Biotech Industry Analysis

UpdatedApr 15, 2025
DataAggregated Company Financials
Companies65
  • 7D1.0%
  • 3M-20.0%
  • 1Y-5.3%
  • YTD-13.4%

Over the last 7 days, the Biotech industry has dropped 12%, and OBI Pharma contributed the most with a 14% decline. The industry has fallen 8.2% in the last year. Looking forward, earnings are forecast to grow by 57% annually.

Industry Valuation and Performance

Has the Taiwanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 15 Apr 2025NT$451.1bNT$28.1b-NT$7,302,014,000.0028x-61.8x16x
Thu, 13 Mar 2025NT$530.2bNT$28.0b-NT$8,413,694,000.0033.8x-63x18.9x
Sat, 08 Feb 2025NT$576.8bNT$24.8b-NT$10,902,841,000.0039.7x-52.9x23.3x
Mon, 06 Jan 2025NT$517.4bNT$24.8b-NT$10,902,841,000.0035.4x-47.5x20.9x
Wed, 04 Dec 2024NT$514.3bNT$24.8b-NT$10,848,764,000.0037.7x-47.4x20.8x
Fri, 01 Nov 2024NT$535.0bNT$23.5b-NT$10,829,095,000.0040.9x-49.4x22.8x
Sun, 29 Sep 2024NT$545.2bNT$23.5b-NT$10,829,095,000.0035.2x-50.3x23.2x
Tue, 27 Aug 2024NT$573.3bNT$23.4b-NT$10,753,713,000.0034.7x-53.3x24.5x
Thu, 25 Jul 2024NT$572.0bNT$21.9b-NT$11,110,100,000.0042.4x-51.5x26.1x
Sat, 22 Jun 2024NT$517.8bNT$21.9b-NT$11,110,643,000.0041.9x-46.6x23.6x
Mon, 20 May 2024NT$489.9bNT$21.9b-NT$10,954,603,000.0039.6x-44.7x22.3x
Wed, 17 Apr 2024NT$448.0bNT$20.8b-NT$12,155,400,000.0049.2x-36.9x21.5x
Fri, 15 Mar 2024NT$435.6bNT$20.7b-NT$9,966,695,000.0042.8x-43.7x21.1x
Sun, 11 Feb 2024NT$436.3bNT$19.9b-NT$9,857,794,000.0040.5x-44.3x21.9x
Tue, 09 Jan 2024NT$465.9bNT$19.8b-NT$9,748,146,000.0039.2x-47.8x23.6x
Thu, 07 Dec 2023NT$478.9bNT$19.9b-NT$9,737,975,000.0043.2x-49.2x24.1x
Sat, 04 Nov 2023NT$470.8bNT$18.4b-NT$10,823,013,000.0049.3x-43.5x25.5x
Mon, 02 Oct 2023NT$477.3bNT$18.3b-NT$10,774,226,000.0043.3x-44.3x26.1x
Wed, 30 Aug 2023NT$482.3bNT$18.3b-NT$10,598,878,000.0041.7x-45.5x26.3x
Fri, 28 Jul 2023NT$471.0bNT$18.7b-NT$10,724,655,000.0044.1x-43.9x25.2x
Sun, 25 Jun 2023NT$470.5bNT$18.7b-NT$10,709,428,000.0042.6x-43.9x25.2x
Tue, 23 May 2023NT$479.5bNT$19.3b-NT$9,957,876,000.0043.3x-48.2x24.9x
Thu, 20 Apr 2023NT$538.7bNT$18.5b-NT$9,609,324,000.0043.2x-56.1x29.1x
Sat, 18 Mar 2023NT$492.3bNT$22.5b-NT$7,203,089,000.0036.9x-68.3x21.9x
Mon, 13 Feb 2023NT$532.0bNT$21.8b-NT$7,832,470,000.0038x-67.9x24.4x
Wed, 11 Jan 2023NT$486.8bNT$21.8b-NT$7,778,690,000.0035.9x-62.6x22.3x
Fri, 09 Dec 2022NT$522.8bNT$21.8b-NT$7,522,211,000.0037.8x-69.5x24x
Sun, 06 Nov 2022NT$468.2bNT$23.1b-NT$6,633,590,000.0037.4x-70.6x20.3x
Tue, 04 Oct 2022NT$508.4bNT$23.1b-NT$6,633,590,000.0037.2x-76.6x22x
Thu, 01 Sep 2022NT$635.3bNT$23.0b-NT$6,443,294,000.0043.7x-98.6x27.6x
Sat, 30 Jul 2022NT$566.7bNT$22.5b-NT$5,642,821,000.0031.8x-100.4x25.1x
Mon, 27 Jun 2022NT$530.6bNT$22.5b-NT$5,642,821,000.0032x-94x23.5x
Wed, 25 May 2022NT$493.7bNT$22.5b-NT$5,642,821,000.0031.7x-87.5x21.9x
Fri, 22 Apr 2022NT$552.3bNT$21.5b-NT$5,726,696,000.0035.1x-96.4x25.7x
Price to Earnings Ratio

-96.4x


Total Market Cap: NT$552.3bTotal Earnings: -NT$5,726,696,000.00Total Revenue: NT$21.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Biotech Industry Price to Earnings3Y Average -58.5x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 23.5x is higher than the industry's current PS ratio of 15.8x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 9.4% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market1.24%
Healthcare1.06%
Biotech0.96%
Biotech0.96%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6446 PharmaEssentiaNT$503.002.5%
+NT$4.2b		65.7%PE56.5x
6550 Polaris GroupNT$33.3013.8%
+NT$3.1b		-50.0%PS239.7x
6541 Tanvex BioPharmaNT$64.1020.5%
+NT$2.6b		39.3%PS440.2x
4728 Sunmax BiotechnologyNT$398.0012.6%
+NT$2.4b		75.7%PE31.9x
4147 TaiMed BiologicsNT$77.709.0%
+NT$1.7b		-11.6%PS34.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6712

NT$167.00

Ever Supreme Bio Technology

7D

9.5%

1Y

-10.2%

6541

NT$64.10

Tanvex BioPharma

7D

20.5%

1Y

39.3%

6446

NT$503.00

PharmaEssentia

7D

2.5%

1Y

65.7%

6550

NT$33.30

Polaris Group

7D

13.8%

1Y

-50.0%

6733

NT$25.65

BioGend Therapeutics

7D

-10.2%

1Y

-31.5%

6827

NT$9.47

MegaPro Biomedical

7D

-4.3%

1Y

-62.3%

6696

NT$120.50

Lin BioScience

7D

13.7%

1Y

54.7%

4174

NT$49.05

OBI Pharma

7D

-4.2%

1Y

-18.0%

6549

NT$7.90

TaiwanJ Pharmaceuticals

7D

-1.3%

1Y

-37.1%

4728

NT$398.00

Sunmax Biotechnology

7D

12.6%

1Y

75.7%

4147

NT$77.70

TaiMed Biologics

7D

9.0%

1Y

-11.6%

4168

NT$17.05

GlycoNex Incorporation

7D

-2.6%

1Y

-33.1%

4157

NT$9.30

TaiGen Biopharmaceuticals Holdings

7D

-3.9%

1Y

-36.5%

6547

NT$44.05

Medigen Vaccine Biologics

7D

7.4%

1Y

-9.2%

6483

NT$13.05

Original BioMedicals

7D

-1.1%

1Y

-24.6%

6564

NT$18.95

Enimmune

7D

-1.0%

1Y

-41.7%